TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMRX

Immuneering Corp

Healthcare · Biotechnology

4.60$ +3.8% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMRX
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.7% 98.2% 91.4% 88.9% 86.8% 75.1% 76.0%
97.8% 96.5% 44.9% 59.4% 57.9% 68.6% 55.5%
97.8% 96.5% 89.5% 86.2% 83.5% 68.6% 74.5%
1.5% 1.3% 0.1% 0.0% 0.0%
-44.6% 0.0%
0.3% 1.8% 0.5% 1.1%
0.0% 4.0% 5.5% 6.5% 12.7% 2.9%
0.3% 0.3% 0.4% 0.7% 0.1%
146.3% 158.5% 6.4% 10.2% 11.7% 21.5% 5.8%
3.6% 5.9% 3.4% 6.6% 7.6% 14.2% 4.3%
0.2% 0.2% 0.3% 0.3% 0.6% 0.2%
2.1% 3.9% 0.8% 2.6% 2.1% 3.7% 0.7%
-46.3% -58.5% 93.6% 89.8% 88.3% 78.5% 94.2%
-61.7% -67.0% -35.6% -89.7% -159.1% -425.5% -120.8%
95.8% 35.2% 15.8% 21.6% 27.7% 56.9% 19.0%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?